Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(1)
About
Ipca Laboratories Ltd.
NSE: IPCALAB
|
BSE: 524494
|
ISIN: INE571A01038
|
Industry: Pharmaceuticals
|
Mid-range Performer
1431.4000
3.20
(
0.22
%)
NSE
Nov 25, 2025
11:47 AM
Volume:
38,244
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Ipca Laboratories Ltd.
16 Feb 2023
1431.40
0.22%
Operating deleverage plays a spoil sport
Buy:
Ipca Laboratories Ltd.
by
Motilal Oswal
Target: 990
Target
Motilal Oswal
Number of FII/FPI investors decreased from 270 to 254 in Sep 2025 qtr
More from Ipca Laboratories Ltd.
Recommended
Market trades flat, Ceigall India secures order to build a 400/220 kV substation at Velgaon
Trendlyne Marketwatch |
25 Nov 2025, 11:22AM
Which stocks did superstar investors sell in Q2FY26?
The Baseline |
24 Nov 2025, 04:46PM
IPCA Labs’ domestic formulations business to drive growth
|
05 Jul 2021